Understanding the phenotypic expression of TRDN variants in diverse genetic backgrounds is crucial for a comprehensive risk assessment, diagnosis, and management of patients suffering from CPVT. Here, TRDN is linked to catecholaminergic polymorphic ventricular tachycardia.